Quantum BioPharma Ltd. — Form 6-K
Filing date: October 6, 2026. The filing identifies Quantum BioPharma Ltd. as a foreign private issuer that files annual reports on Form 20-F.
Business context and reporting period
This is an administrative Form 6-K for October 2026, signed by Chief Financial Officer Donal Carroll. The filing lists Exhibit 99.1, a press release dated October 6, 2026, but the press release itself is not included in the provided text.
Financial results and changes
The provided filing text contains no revenue, profit, cash flow, margin, debt, liquidity, guidance, or comparable-period information. It does not provide a clear value for any financial metric or describe material financial changes.
Investor items to verify
- Obtain and review Exhibit 99.1, the referenced October 6, 2026 press release.
- Check the press release and other filings for financial results, outlook, risks, contingencies, or unusual items not included in this 6-K text.